Aarti Pharmalabs Ltd

Common Name
Aarti Pharmalabs
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,162
Ticker
AARTIPHARM
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Aarti Pharmalabs Ltd. is an integrated pharmaceutical company engaged in the development and production of active pharmaceutical ingredients. The primary function of the company is to support the phar...

Aarti Pharmalabs's GHG Emissions Data Preview

In 2024, Aarti Pharmalabs completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Aarti Pharmalabs has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Aarti Pharmalabs’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Aarti Pharmalabs’s data sources below and access millions more through our Disclosure Search.

a. Aarti Pharmalabs's Sustainability Report 2024
a. Aarti Pharmalabs's Sustainability Report 2024

Insights into Aarti Pharmalabs's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Aarti Pharmalabs amounted to 183,865.78 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Aarti Pharmalabs increased by 56.97%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Aarti Pharmalabs's Scope 1 Emissions Over Time

20232024025 k50 k75 k100 ktCO2e+136%
  • Total Scope 1
  • Year-over-Year Change

What are Aarti Pharmalabs's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Aarti Pharmalabs were 88,101.32 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2023), Aarti Pharmalabs's Scope 1 emissions increased by 135.63%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Aarti Pharmalabs's Scope 2 emissions?

In 2024, Aarti Pharmalabs reported Scope 2 greenhouse gas (GHG) emissions of 95,764.46 tCO₂e without specifying the calculation method. a

Has Aarti Pharmalabs reduced its Scope 2 emissions over time?

Compared to the previous year (2023), Aarti Pharmalabs's Scope 2 emissions (Unspecified Calculation Method) rose by 20.09% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Aarti Pharmalabs use for Scope 2 reporting?

In 2024, Aarti Pharmalabs reported its Scope 2 emissions using an unspecified methodology. a

Aarti Pharmalabs's Scope 2 Emissions Over Time

20232024025 k50 k75 k100 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Aarti Pharmalabs’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Aarti Pharmalabs reported Scope 1 greenhouse gas (GHG) emissions of 88,101.32 tCO₂e and total revenues of USD 218 millions. This translates into an emissions intensity of 404.68 tCO₂e per millions USD. a

Aarti Pharmalabs's Scope 1 Emissions Intensity Compared to Peers

1001,00020,000200,0002,000,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)OJIOLCPYear: 2025Scope 1: 45,920 tCO2eRevenue: $M 242Scope 1 Intensity: 189.70 tCO2e/$MDivi's LaboratoriesYear: 2025Scope 1: 339,941 tCO2eRevenue: $M 1,091Scope 1 Intensity: 311.47 tCO2e/$MAurobindo PharmaYear: 2025Scope 1: 750,616 tCO2eRevenue: $M 3,672Scope 1 Intensity: 204.39 tCO2e/$MMankind PharmaYear: 2025Scope 1: 6,538 tCO2eRevenue: $M 1,429Scope 1 Intensity: 4.58 tCO2e/$MZydus LifesciencesYear: 2023Scope 1: 44,792 tCO2eRevenue: $M 2,056Scope 1 Intensity: 21.79 tCO2e/$MAlembic PharmaceuticalsYear: 2025Scope 1: 80,278 tCO2eRevenue: $M 765Scope 1 Intensity: 104.88 tCO2e/$MAjanta PharmaYear: 2025Scope 1: 6,392 tCO2eRevenue: $M 537Scope 1 Intensity: 11.90 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MGranules IndiaYear: 2024Scope 1: 58,254 tCO2eRevenue: $M 538Scope 1 Intensity: 108.19 tCO2e/$MAarti PharmalabsYear: 2024Scope 1: 88,101 tCO2eRevenue: $M 218Scope 1 Intensity: 404.68 tCO2e/$M

How does Aarti Pharmalabs's GHG emissions intensity compare to its peers?

In 2024, Aarti Pharmalabs reported a Scope 1 emissions intensity of 404.68 tCO₂e per millions USD. Compared to the peer group median of 24.05 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Aarti Pharmalabs rank on GHG emissions intensity within its industry?

In 2024, Aarti Pharmalabs ranked 24 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Aarti Pharmalabs among the least efficient performers, with one of the highest emissions intensities in its sector. a

Want Full Access to Aarti Pharmalabs's GHG Emissions Dataset?
Sign Up